Clin2
NCT06399263Possibly a fitRecruiting

Psilocybin for anorexia in young adults

Anorexia Nervosa

Treatments studied

Part of Mental health clinical trials.

This trial tests whether a single dose of psilocybin (a psychedelic substance) can help treat anorexia nervosa in young adults. It involves taking the medication in a safe, supervised setting and participating in therapy sessions with a support person.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
40 people
Ages
18 years to 25 years
Study type
Interventional

Who can take part

  • You are between 18 and 25 years old.
  • You have anorexia nervosa (any type) and are currently experiencing symptoms.
  • You can read and write comfortably in English.
  • You are willing to bring one or two family members or close friends to join some therapy sessions with you.
  • You are not pregnant, breastfeeding, or at high risk for self-harm or suicide.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07169747Recruiting· Phase 2
Psilocybin with therapy for young adults with anorexia

This study tests two different doses of psilocybin, a substance that may help change thinking patterns, given alongside psychological support to young adults with anorexia nervosa. It aims to see if it is safe and helpful for weight recovery and mental health.

Lund
NCT07479550Not yet recruiting· Phase 2
Psilocybin under anesthesia for depression

This trial tests whether a single dose of psilocybin, given while you are under anesthesia, can help treat major depression. You will be monitored closely during and after the session.

Stanford, California
NCT07386730Recruiting· Phase 1
Psychedelic therapy study for older adults with low well-being

This study tests if a single dose of psilocybin (a psychedelic) or dextromethorphan (a cough suppressant) can improve well-being in healthy older adults who feel their well-being is below average. It aims to understand how these drugs might help boost mood and life satisfaction.

San Francisco, California
NCT06160232Recruiting· Phase 2
Psilocybin therapy for severe alcohol use disorder

This trial tests whether psilocybin, a psychedelic substance, combined with talk therapy can help people with severe alcohol use disorder stop or reduce drinking. Participants will first complete a 4-week inpatient detox program before receiving psilocybin in a supervised setting.

Brussels
NCT07607938Not yet recruiting· Phase 1
Psilocybin for Depression With Loss of Interest or Pleasure

This study tests whether psilocybin, a naturally occurring psychedelic compound, can help people with depression who experience anhedonia—a loss of interest or pleasure in activities. Researchers will monitor your brain activity and mood changes over time to see if this treatment is safe and helpful.

New York, New York
NCT06444243Not yet recruiting· Phase 2
Psilocybin therapy for alcohol use disorder

This trial tests whether a psilocybin (magic mushroom) therapy session can help people with alcohol use disorder reduce their drinking. You'll have one or two guided sessions with a therapist, plus support before and after, to see if it helps you change your drinking habits.

Hear when a new Anorexia Nervosa trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.